RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: prostate carcinoma
Accession: DOID:10286
browse the term
Definition: A prostate cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells. (DO)
Synonyms: exact_synonym: carcinoma of prostate
narrow_synonym: metastatic prostate carcinoma
xref: EFO:0001663 ; NCI:C128122 ; NCI:C4863
For additional species annotation, visit the
Alliance of Genome Resources .
G
Akt2
AKT serine/threonine kinase 2
treatment
ISO
RGD
PMID:24838891
RGD:13504674
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:82,883,547...82,933,817
G
Angpt1
angiopoietin 1
ISO
protein:increased expression:prostate gland
RGD
PMID:11326698
RGD:1643336
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:73,531,486...73,784,067
G
Atf4
activating transcription factor 4
treatment
ISO
RGD
PMID:25680860
RGD:13504680
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:111,804,183...111,806,446
G
Azgp1
alpha-2-glycoprotein 1, zinc-binding
exacerbates
ISO
RGD
PMID:11309332
RGD:153350158
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
G
Bad
BCL2-associated agonist of cell death
ISO
protein:increased expression:prostate gland
RGD
PMID:11781193
RGD:2292676
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
disease_progression
ISO
protein:increased expression:prostate gland epithelium
RGD
PMID:17454944
RGD:1643355
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2l1
Bcl2-like 1
ISO
RGD
PMID:17653717
RGD:1643474
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bcl2l14
Bcl2-like 14
ISO
mRNA:decreased expression:prostate gland
RGD
PMID:14999772
RGD:2315712
NCBI chr 4:167,217,561...167,258,723
Ensembl chr 4:167,219,871...167,258,086
G
Bmp2
bone morphogenetic protein 2
disease_progression
ISO
protein:increased expression:prostate gland
RGD
PMID:16519147
RGD:1643592
NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:120,812,882...120,821,397
G
Bmp4
bone morphogenetic protein 4
disease_progression
ISO
protein:increased expression:prostate
RGD
PMID:16519147
RGD:1643592
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:19,618,542...19,623,306
G
Casp6
caspase 6
IEP
mRNA:increased expression:prostate gland
RGD
PMID:11406539
RGD:1582381
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Cdk13
cyclin-dependent kinase 13
ameliorates
ISO
RGD
PMID:33390186
RGD:155641232
NCBI chr17:47,251,145...47,344,675
Ensembl chr17:47,251,163...47,341,721
G
Cga
glycoprotein hormones, alpha polypeptide
ISO
mRNA:increased expression:prostate gland
RGD
PMID:12180238
RGD:2293634
NCBI chr 5:54,283,109...54,295,464
Ensembl chr 5:49,487,068...49,499,191
G
Chi3l1
chitinase 3 like 1
severity
ISO
protein:increased secretion:serum (human)
RGD
PMID:16372331
RGD:4892641
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
G
Crkl
CRK like proto-oncogene, adaptor protein
ISO
protein:decreased tyrosine phosphorylation:prostate gland
RGD
PMID:16391854
RGD:7488899
NCBI chr11:97,033,033...97,067,457
Ensembl chr11:83,526,530...83,563,238
G
E2f5
E2F transcription factor 5
ameliorates
ISO
RGD
PMID:33390186
RGD:155641232
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
G
Eif3h
eukaryotic translation initiation factor 3, subunit H
ISO
DNA:amplification
RGD
PMID:14997205
RGD:2289900
NCBI chr 7:83,091,037...83,174,451
Ensembl chr 7:83,091,039...83,174,451
G
Ghrh
growth hormone releasing hormone
ISO
mRNA:increased expression:prostate
RGD
PMID:12364462
RGD:2289976
NCBI chr 3:145,992,762...146,012,528
Ensembl chr 3:145,992,763...146,011,889
G
Hdac2
histone deacetylase 2
disease_progression
ISO
protein:increased expression:prostate gland
RGD
PMID:18212746
RGD:2306214
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:40,548,250...40,571,609
G
Hdac3
histone deacetylase 3
ISO
protein:increased expression:prostate gland
RGD
PMID:18212746
RGD:2306214
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
G
Hmbs
hydroxymethylbilane synthase
ISO
mRNA:decreased expression:tumor:in matched malignant and non-malignant sample pairs (p = 0.009) (human)
RGD
PMID:16211407
RGD:2301682
NCBI chr 8:44,673,554...44,680,950
Ensembl chr 8:44,673,554...44,680,957
G
Igf1r
insulin-like growth factor 1 receptor
IEP
RGD
PMID:18079205
RGD:13504770
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
Inha
inhibin subunit alpha
ISO
RGD
PMID:11818495
RGD:2290381
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
RGD
PMID:16413376
RGD:2290480
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Met
MET proto-oncogene, receptor tyrosine kinase
disease_progression
ISO
protein:increased expression:primary tumor, metastatic carcinoma (human)
RGD
PMID:7639332
RGD:2317554
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:45,790,791...45,897,876
G
Mgp
matrix Gla protein
ISO
RGD
PMID:1399132
RGD:2293578
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Mki67
marker of proliferation Ki-67
IDA
RGD
PMID:22268182
RGD:6483545
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
G
Mmp7
matrix metallopeptidase 7
IDA
RGD
PMID:11406539
RGD:1582381
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:4,848,186...4,855,902
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
ISO
RGD
PMID:8618340
RGD:2299063
NCBI chr10:79,403,939...79,426,620
Ensembl chr10:78,906,083...78,916,408
G
Pdgfb
platelet derived growth factor subunit B
ISO
RGD
PMID:23297038
RGD:13506769
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfd
platelet derived growth factor D
disease_progression
ISO
RGD
PMID:21098708
RGD:13506773
NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395
G
Plk1
polo-like kinase 1
ISO
mRNA, protein:increased expression:prostate gland
RGD
PMID:15948124
RGD:2299939
NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:176,716,420...176,726,400
G
Prkca
protein kinase C, alpha
ISO
RGD
PMID:9474241
RGD:2292463
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:92,894,012...93,288,012
G
Sars1
seryl-tRNA synthetase 1
ISO
mRNA:decreased expression:prostate gland (human)
RGD
PMID:26317032
RGD:41410436
NCBI chr 2:196,065,543...196,081,240
Ensembl chr 2:196,065,430...196,081,277
G
Skp2
S-phase kinase associated protein 2
ISO
RGD
PMID:12670908
RGD:2315046
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
G
Spint1
serine peptidase inhibitor, Kunitz type 1
disease_progression
ISO
protein:decreased expression:prostate gland (human)
RGD
PMID:16492908
RGD:1581314
NCBI chr 3:126,685,017...126,697,957
Ensembl chr 3:106,231,444...106,244,119
G
Spp1
secreted phosphoprotein 1
ISO
RGD
PMID:16331611
RGD:1581362
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Stat3
signal transducer and activator of transcription 3
ISO
protein:increased activity:prostate gland
RGD
PMID:11987152 PMID:18210874
RGD:2298538 , RGD:2291910
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Stat6
signal transducer and activator of transcription 6
ISO
RGD
PMID:11912448
RGD:2298560
NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:63,479,642...63,498,495
G
Tmbim6
transmembrane BAX inhibitor motif containing 6
ISO
mRNA:increased expression:prostate gland
RGD
PMID:12875974
RGD:2291960
NCBI chr 7:130,527,313...130,542,567
Ensembl chr 7:130,527,316...130,543,633
G
Tp73
tumor protein p73
disease_progression
ISO
mRNA, protein:increased expression:prostate gland
RGD
PMID:16254107
RGD:2290587
NCBI chr 5:169,903,801...169,988,075
Ensembl chr 5:164,621,377...164,681,128
G
Akr1c3
aldo-keto reductase family 1, member C3
ISO
mRNA,protein:increased expression:epithelial cell: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25555457 PMID:23196782
RGD:10053626
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:66,110,963...66,127,873
G
Ar
androgen receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18985049 PMID:24740322 PMID:28500234 PMID:28757136
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Asf1b
anti-silencing function 1B histone chaperone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29581250
NCBI chr19:41,085,786...41,100,352
Ensembl chr19:24,181,028...24,195,549
G
Ccne2
cyclin E2
treatment
ISO
RGD
PMID:27431942
RGD:13504681
NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:24,284,922...24,297,632
G
Cd46
CD46 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30185663
NCBI chr13:109,104,122...109,134,903
Ensembl chr13:106,574,858...106,660,445
G
Cenpk
centromere protein K
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29581250
NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706
G
Chd1
chromodomain helicase DNA binding protein 1
ISO
DNA:mutations: :
RGD
PMID:22722839
RGD:9587749
NCBI chr 1:56,661,743...56,729,119
Ensembl chr 1:56,664,054...56,728,125
G
Kdm1a
lysine demethylase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29581250
NCBI chr 5:148,782,976...148,838,319
Ensembl chr 5:148,782,976...148,838,319
G
Nuf2
NUF2 component of NDC80 kinetochore complex
treatment
ISO
RGD
PMID:28498618
RGD:28867238
NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
G
Stat5a
signal transducer and activator of transcription 5A
disease_progression treatment
ISO
DNA:CNV: :prostate (human)
RGD
PMID:23660011 PMID:23660011
RGD:151667415 , RGD:151667415
NCBI chr10:86,285,859...86,310,187
Ensembl chr10:85,785,537...85,809,866
G
Trim24
tripartite motif-containing 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27238081
NCBI chr 4:66,567,342...66,692,029
Ensembl chr 4:66,566,686...66,717,241
G
Zfp217
zinc finger protein 217
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29581250
NCBI chr 3:158,890,464...158,931,148
Ensembl chr 3:158,892,265...158,913,040
G
Zfp367
zinc finger protein 367
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29581250
NCBI chr17:970,896...990,025
Ensembl chr17:965,161...984,287
G
Adipoq
adiponectin, C1Q and collagen domain containing
susceptibility
ISO
DNA:SNPs, haplotypes:5' utr, introns, exon:multiple
RGD
PMID:21397927
RGD:8694410
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adipor1
adiponectin receptor 1
susceptibility
ISO
DNA:SNPs, haplotype:intron, exon: (rs12733285, rs7539452) (human)
RGD
PMID:21397927
RGD:8694410
NCBI chr13:45,859,461...45,879,248
Ensembl chr13:45,859,533...45,879,241
G
Akt1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:20638364
RGD:13504677
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
treatment
ISO
RGD
PMID:20638364
RGD:13504677
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:82,883,547...82,933,817
G
Akt3
AKT serine/threonine kinase 3
treatment
ISO
RGD
PMID:20638364
RGD:13504677
NCBI chr13:91,475,839...91,758,060
Ensembl chr13:88,946,091...89,225,708
G
Ar
androgen receptor
treatment
IDA
RGD
PMID:18439064
RGD:10043341
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Bin1
bridging integrator 1
ISO
RGD
PMID:12532338
RGD:1580047
NCBI chr18:24,282,840...24,341,461
Ensembl chr18:24,009,653...24,067,263
G
Birc6
baculoviral IAP repeat-containing 6
ameliorates
ISO
mRNA:increased expression:prostate gland (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 6:20,722,922...20,916,396
Ensembl chr 6:20,722,922...20,916,434
G
Birc7
baculoviral IAP repeat-containing 7
exacerbates
ISO
mRNALincreased expression:prostate gland (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 3:168,047,824...168,052,606
Ensembl chr 3:168,047,824...168,052,606
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
RGD
PMID:19079609
RGD:2315868
NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:68,384,649...68,510,463
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
treatment
ISO
RGD
PMID:25003983
RGD:18337280
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
G
Ccnb1
cyclin B1
severity
ISO
RGD
PMID:10193948
RGD:2315940
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
G
Ccne2
cyclin E2
ISO
RGD
PMID:25315431
RGD:13504706
NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:24,284,922...24,297,632
G
Cd9
CD9 molecule
disease_progression
ISO
DNA, mRNA:deletion, point mutation, decreased expression:prostate gland
RGD
PMID:17406028
RGD:2326197
NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:158,256,328...158,289,222
G
Chd4
chromodomain helicase DNA binding protein 4
ISO
mRNA:decreased expression:prostate gland (human)
RGD
PMID:28486105
RGD:153323299
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
treatment
ISO
RGD
PMID:26379052
RGD:13504774
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:242,959,760...242,995,065
G
Clu
clusterin
treatment
IEP
RGD
PMID:24118288
RGD:9068419
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
G
Creb3l4
cAMP responsive element binding protein 3-like 4
ISO
RGD
PMID:17270658 PMID:11830526
RGD:13504714 , RGD:13504715
NCBI chr 2:175,690,340...175,695,846
Ensembl chr 2:175,690,335...175,695,932
G
Ctnnb1
catenin beta 1
ISO
ClinVar Annotator: match by term: Prostate adenocarcinoma
ClinVar
PMID:10192393 PMID:25741868 PMID:26619011
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Dnmt1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:prostate gland:
RGD
PMID:17178860
RGD:2289681
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3a
DNA methyltransferase 3 alpha
ISO
mRNA:increased expression:prostate gland:
RGD
PMID:17178860
RGD:2289681
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:26,822,609...26,896,687
G
Dnmt3b
DNA methyltransferase 3 beta
ISO
mRNA,protein:increased expression:prostate gland:
RGD
PMID:17178860
RGD:2289681
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:142,130,592...142,169,124
G
Fgf2
fibroblast growth factor 2
disease_progression
ISO
RGD
PMID:14522896
RGD:2290290
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fgfr1
Fibroblast growth factor receptor 1
ISO
RGD
PMID:23576558 PMID:18068632
RGD:13504748 , RGD:2298702
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:66,494,042...66,547,350
G
Grb2
growth factor receptor bound protein 2
ISO
RGD
PMID:26103942
RGD:11056009
NCBI chr10:101,380,354...101,448,138
Ensembl chr10:100,869,718...100,949,309
G
Hras
HRas proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Adenocarcinoma of prostate | ClinVar Annotator: match by term: Prostate adenocarcinoma
ClinVar
PMID:1904555 PMID:3510078 PMID:11150980 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19371735 PMID:19382114 PMID:19669404 PMID:20660566 PMID:20979192 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23429430 PMID:23751039 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24803665 PMID:25157968 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32165824 PMID:32371413 PMID:33372952 PMID:34008892 More...
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:196,296,263...196,300,615
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
ISO
ClinVar Annotator: match by term: Prostate adenocarcinoma
ClinVar
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 PMID:21352804 PMID:21446021 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22898539 PMID:23558169 PMID:24606448 PMID:25043048 PMID:25157968 PMID:25741868 PMID:26619011 PMID:27993330 PMID:30231226 More...
NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:66,534,146...66,563,708
G
Igf1r
insulin-like growth factor 1 receptor
treatment disease_progression
ISO IMP
RGD
PMID:26452103 PMID:8692980 PMID:25442907 PMID:25862373
RGD:13504753 , RGD:13504771 , RGD:13504768 , RGD:13504767
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
ISO
RGD
PMID:27196761
RGD:13504772
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Ilk
integrin-linked kinase
disease_progression
ISO
protein:increased expression:tumor: high-grade tumors versus adjacent BHP (P<0.001), BHP from cancer-free patients (P<0.002), or low-grade tumors (P=0.003), also associated with proliferative index (P=0.001), but inversely related to 5-year survival (p=0.004) (human)
RGD
PMID:11448915
RGD:2301734
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
G
Insr
insulin receptor
treatment
ISO
RGD
PMID:26452103
RGD:13504753
NCBI chr12:5,991,135...6,129,275
Ensembl chr12:1,197,100...1,330,883
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
disease_progression
ISO
RGD
PMID:9748134
RGD:2290484
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Kdr
kinase insert domain receptor
ISO IEP
protein:increased expression:prostate gland
RGD
PMID:17491265 PMID:20808233
RGD:2291925 , RGD:5684541
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Map2k1
mitogen activated protein kinase kinase 1
disease_progression
IDA
metastasis; inhibition reduced invasiveness of prostate tumor cells
RGD
PMID:12688676
RGD:2292631
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:64,683,449...64,755,147
G
Mapk1
mitogen activated protein kinase 1
treatment
ISO
RGD
PMID:28492138 PMID:22139534
RGD:13504818 , RGD:13504820
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Myc
MYC proto-oncogene, bHLH transcription factor
ISO
human gene in mouse model
RGD
PMID:14522256 PMID:20195545
RGD:7207413 , RGD:7207781
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Ncoa2
nuclear receptor coactivator 2
ameliorates
ISO
human cells in mouse model
RGD
PMID:25664849
RGD:153002575
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
G
Nfkbia
NFKB inhibitor alpha
severity
ISO
protein:increased serine phosphorylation
RGD
PMID:15712212 PMID:15073126
RGD:2298768 , RGD:13506768
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Pam
peptidylglycine alpha-amidating monooxygenase
ISO
mRNA:increased expression:prostate gland (human)
RGD
PMID:11221851
RGD:6483769
NCBI chr 9:97,998,581...98,271,966
Ensembl chr 9:98,122,916...98,271,965
G
Pdgfa
platelet derived growth factor subunit A
ISO
protein:increased expression:prostate
RGD
PMID:7524068
RGD:2292156
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:15,645,541...15,666,497
G
Pdgfra
platelet derived growth factor receptor alpha
ISO
protein:increased expression:prostate
RGD
PMID:7524068
RGD:2292156
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,005,839...33,054,335
G
Pdpk1
3-phosphoinositide dependent protein kinase-1
treatment
ISO
RGD
PMID:17562488
RGD:13506808
NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,105,498...13,174,623
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
ISO
ClinVar Annotator: match by term: Adenocarcinoma of prostate
ClinVar
PMID:15016963 PMID:15254419 PMID:15647370 PMID:15805248 PMID:18676830 PMID:18725974 PMID:19366826 PMID:19903786 PMID:20453058 PMID:20619739 PMID:22162582 PMID:22162589 PMID:25741868 PMID:26619011 More...
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:115,174,984...115,249,032
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
treatment
ISO
RGD
PMID:18755892
RGD:13217420
NCBI chr 8:108,474,017...108,579,140
Ensembl chr 8:99,594,644...99,699,663
G
Prkcq
protein kinase C, theta
IEP
mRNA:increased expression:prostate
RGD
PMID:8180127
RGD:1625625
NCBI chr17:72,156,215...72,288,508
Ensembl chr17:67,246,394...67,378,704
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
treatment
ISO
RGD
PMID:15754006
RGD:13506897
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:148,679,530...148,740,317
G
Rela
RELA proto-oncogene, NF-kB subunit
disease_progression
ISO
protein:increased expression:prostate gland
RGD
PMID:15712212 PMID:15073126
RGD:2298768 , RGD:13506768
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Stat1
signal transducer and activator of transcription 1
disease_progression
ISO
protein:increased activity:prostate
RGD
PMID:9748134
RGD:2290484
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
G
Tert
telomerase reverse transcriptase
treatment
ISO
RGD
PMID:19903903
RGD:11038656
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
G
Tmprss2
transmembrane serine protease 2
disease_progression
ISO
protein:increased expression, altered localization:prostate gland
RGD
PMID:18338334
RGD:2324904
NCBI chr11:36,934,306...36,973,779
Ensembl chr11:36,934,306...36,973,715
G
Tp53
tumor protein p53
ISO
ClinVar Annotator: match by term: Adenocarcinoma of prostate ClinVar Annotator: match by term: Prostate adenocarcinoma
ClinVar
PMID:1565143 PMID:1565144 PMID:11370630 PMID:12826609 PMID:19468865 PMID:21305319 PMID:21761402 PMID:22672556 PMID:25584008 PMID:25741868 PMID:26619011 PMID:27616075 PMID:28369373 PMID:28492532 PMID:29070607 PMID:29979965 PMID:30224644 PMID:33332384 More...
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Amacr
alpha-methylacyl-CoA racemase
disease_progression
ISO
RGD
PMID:18343427
RGD:2315630
NCBI chr 2:61,673,291...61,685,381
Ensembl chr 2:59,946,153...59,958,255
G
Ang
angiogenin
ISO
RGD
PMID:19276260
RGD:2325697
NCBI chr15:26,786,233...26,796,883
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
ISO
protein:increased expression, altered localization:prostate, cytoplasm
RGD
PMID:11309329
RGD:2315666
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:24,144,362...24,146,785
G
Ar
androgen receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20601956
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Areg
amphiregulin
ISO
protein:increased expression:prostate gland
RGD
PMID:14716741
RGD:2292659
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:16,972,187...16,981,535
G
Atm
ATM serine/threonine kinase
ISO
protein:increased serine phosphorylation:prostate gland
RGD
PMID:16997395
RGD:2293869
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
G
Aurka
aurora kinase A
ISO
protein:increased expression:prostate gland
RGD
PMID:15754349 PMID:16707419
RGD:2293883 , RGD:2293877
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:161,128,313...161,144,390
G
Aurkb
aurora kinase B
ISO
RGD
PMID:16707419
RGD:2293877
NCBI chr10:54,243,116...54,249,675
Ensembl chr10:53,745,142...53,750,837
G
Btg2
BTG anti-proliferation factor 2
ISO
protein:decreased expression:prostate gland
RGD
PMID:11470758
RGD:2289070
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:45,531,925...45,535,628
G
Carm1
coactivator-associated arginine methyltransferase 1
ISO
protein:increased expression:prostate gland
RGD
PMID:15221992
RGD:2293206
NCBI chr 8:20,097,262...20,141,950
Ensembl chr 8:20,097,254...20,147,689
G
Ccnd1
cyclin D1
ISO
mRNA, protein:decreased expression:prostate gland
RGD
PMID:14968434
RGD:2289283
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccne1
cyclin E1
ISO
mRNA, protein:increased expression:prostate gland
RGD
PMID:14968434
RGD:2289283
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:90,781,949...90,791,101
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22581815
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:20932324 PMID:18691549
RGD:2299085
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Creb3l4
cAMP responsive element binding protein 3-like 4
severity
ISO
RGD
PMID:17270658
RGD:13504714
NCBI chr 2:175,690,340...175,695,846
Ensembl chr 2:175,690,335...175,695,932
G
Csf1r
colony stimulating factor 1 receptor
ISO
protein:increased expression:prostate gland
RGD
PMID:12381783
RGD:2293712
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:54,546,659...54,590,415
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
ISO
RGD
PMID:19700748
RGD:7257711
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:54,553,165...54,580,758
G
Dnmt1
DNA methyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22581815
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:19,440,611...19,486,659
G
Esr1
estrogen receptor 1
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16220300 PMID:22025007
RGD:8553211
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
treatment
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16220300 PMID:22025007
RGD:8553211
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
Fgf6
fibroblast growth factor 6
ISO
protein:increased expression:prostate gland
RGD
PMID:2289066
RGD:2301089
NCBI chr 4:161,541,089...161,549,624
Ensembl chr 4:159,854,913...159,863,447
G
Fgf8
fibroblast growth factor 8
ISO
RGD
PMID:12208767
RGD:2301097
NCBI chr 1:254,533,504...254,539,605
Ensembl chr 1:244,584,652...244,590,359
G
Fgfr1
Fibroblast growth factor receptor 1
ISO
RGD
PMID:18068632
RGD:2298702
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:66,494,042...66,547,350
G
Fgfr2
fibroblast growth factor receptor 2
ISO
RGD
PMID:14695195
RGD:2301192
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:184,745,420...184,850,626
G
Flt1
Fms related receptor tyrosine kinase 1
ISO
protein:decreased expression:prostate gland
RGD
PMID:10893635
RGD:2301255
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626
G
Fzd4
frizzled class receptor 4
ISO
protein:increased expression:prostate gland
RGD
PMID:18068632
RGD:2298702
NCBI chr 1:143,279,934...143,288,799
Ensembl chr 1:143,280,065...143,285,724
G
Gstp1
glutathione S-transferase pi 1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22581815 PMID:24312188
RGD:10401940
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Hdac1
histone deacetylase 1
ISO
protein:increased expression:prostate gland
RGD
PMID:15042618
RGD:2306219
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:141,853,989...141,881,111
G
Igf1
insulin-like growth factor 1
IEP
protein:increased expression:prostate gland
RGD
PMID:19171036
RGD:2306713
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Kras
KRAS proto-oncogene, GTPase
ISO
RGD
PMID:19117991
RGD:2314913
NCBI chr 4:179,916,255...179,949,613
G
Lef1
lymphoid enhancer binding factor 1
ISO
RGD
PMID:27067790
RGD:11531513
NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:219,666,592...219,779,794
G
Lrp1
LDL receptor related protein 1
IEP
protein:increased expression:prostate gland
RGD
PMID:14623925
RGD:1625030
NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:63,380,356...63,460,910
G
Map2k4
mitogen activated protein kinase kinase 4
disease_progression
ISO
RGD
PMID:17577251
RGD:2293334
NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,344,915...50,447,993
G
Map2k6
mitogen-activated protein kinase kinase 6
disease_progression
ISO
RGD
PMID:17577251
RGD:2293334
NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,373,204...95,488,293
G
Map2k7
mitogen activated protein kinase kinase 7
disease_progression
ISO
RGD
PMID:17577251
RGD:2293334
NCBI chr12:7,389,032...7,398,377
Ensembl chr12:2,591,219...2,604,222
G
Mt2
metallothionein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16574721
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784
G
Myc
MYC proto-oncogene, bHLH transcription factor
ISO
RGD
PMID:10861747
RGD:10059615
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Phb1
prohibitin 1
ISO
mRNA, protein:increased expression:prostate gland
RGD
PMID:18384941
RGD:2292382
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
G
Pim1
Pim-1 proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23565217
NCBI chr20:7,556,496...7,560,747
Ensembl chr20:7,554,921...7,559,174
G
Prss8
serine protease 8
disease_progression
ISO
mRNA, protein:increased expression:prostate gland
RGD
PMID:12518323
RGD:2292484
NCBI chr 1:182,536,229...182,540,745
Ensembl chr 1:182,536,229...182,540,815
G
Pten
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19081794 PMID:22581815 PMID:18268330
RGD:2292497
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
protein:altered localization
RGD
PMID:18468781
RGD:2300123
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
protein:increased expression:prostate gland
RGD
PMID:16278667 PMID:15570007
RGD:2298767 , RGD:2298769
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rxra
retinoid X receptor alpha
IEP
protein:decreased expression:prostate
RGD
PMID:15318950
RGD:1643115
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:10,989,832...11,073,712
G
Slc30a4
solute carrier family 30 member 4
ISO
protein:decreased expression:prostate gland
RGD
PMID:12955079
RGD:2299948
NCBI chr 3:130,206,852...130,228,888
Ensembl chr 3:109,753,273...109,775,306
G
Smad4
SMAD family member 4
ISO
protein:increased expression:prostate gland
RGD
PMID:15017584
RGD:2300005
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:67,243,742...67,274,438
G
St14
ST14 transmembrane serine protease matriptase
ISO
protein:increased expression:prostate gland
RGD
PMID:18813126
RGD:2315088
NCBI chr 8:29,540,805...29,581,704
Ensembl chr 8:29,540,811...29,581,517
G
Stk11
serine/threonine kinase 11
ISO
RGD
PMID:18381428
RGD:2291943
NCBI chr 7:10,225,204...10,241,965
Ensembl chr 7:9,575,269...9,591,315
G
Timp4
TIMP metallopeptidase inhibitor 4
ISO
RGD
PMID:16940965
RGD:2290433
NCBI chr 4:148,306,021...148,312,558
Ensembl chr 4:148,304,490...148,312,558
G
Top2b
DNA topoisomerase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20601956
NCBI chr15:11,482,089...11,542,464
Ensembl chr15:9,051,341...9,112,085
G
Tp63
tumor protein p63
ISO
protein:decreased expression:prostate gland CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22581815 PMID:17189982 PMID:17982114
RGD:2315434 , RGD:2315433
NCBI chr11:88,343,647...88,554,543
Ensembl chr11:74,838,859...75,049,398
G
Brca2
BRCA2, DNA repair associated
ISO
ClinVar Annotator: match by term: Metastatic Prostate Small Cell Carcinoma
ClinVar
PMID:10550133 PMID:10660329 PMID:11597388 PMID:11802209 PMID:15024741 PMID:15689453 PMID:18393245 PMID:20104584 PMID:21952622 PMID:22009639 PMID:22144684 PMID:22535016 PMID:22666503 PMID:22798144 PMID:24033266 PMID:25525159 PMID:25741868 PMID:26439132 PMID:26467025 PMID:27257965 PMID:27433846 PMID:27836010 PMID:28039656 PMID:28324225 PMID:28492532 PMID:28724667 PMID:28993434 PMID:29084914 PMID:29176636 PMID:29339979 PMID:29446198 PMID:30078507 PMID:30093976 PMID:30274973 PMID:30287823 PMID:30322717 PMID:30702160 PMID:30720243 PMID:30787465 PMID:30875412 PMID:31214711 PMID:31263054 PMID:31447099 PMID:31742824 PMID:31825140 PMID:32295079 PMID:32318955 PMID:32341426 PMID:32467295 PMID:32710294 PMID:32853339 PMID:33471991 PMID:33608381 PMID:33918338 PMID:36988593 More...
NCBI chr12:4,895,092...4,939,340
Ensembl chr12:59,819...100,567
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all